Nuclear Shock and Options Signals: Power Names in Focus
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Options flow is flashing caution on US utilities this week. The sharpest signal comes from SO. ORTEX alt data shows Southern Company's reactor output fell 10 standard deviations below its own history as of 27 October, the most extreme deviation in the nuclear output dataset. With SO carrying 4.7 days to cover and a short score of 37.7, the stock's next options expiry on 30 October falls squarely in the middle of this uncertainty. Defensive put activity in the utilities sector is worth watching closely.
AEP carries the heaviest short burden among large-cap utilities, at 7.15 days to cover. Its options chain is sparser than peers, with the nearest expiry not until 20 November. That thin liquidity can amplify moves when news hits.
On the bearish-bets leaderboard, META and AMD topped the negative options flow screen over the past seven days. META is also down 6% year-to-date with an RSI of 31.9, near oversold territory. Its earnings expiry on 5 November concentrates risk further.
Micron stands out on the other side. It leads the negative-bets volume table yet carries an ORTEX stock score of 98.1 out of 100 and analyst upside of 68%. That divergence between bearish options flow and fundamental strength is a classic setup traders hunt for reversals.
GPIX, the Goldman Sachs S&P 500 Premium Income ETF, is drawing unusual retail attention. Wikipedia pageview data tracked by ORTEX shows a 10-standard-deviation spike in the week to 21 October. Premium income strategies sell covered calls by design, so a sudden retail surge into that product could subtly pressure index call markets near term.
Stocks in this article
How this article was generated
- Generated
- 29 Oct 2026, 08:44
- Prompt version
- v1.0
- Data sources
- Options flowORTEX Alpha signalsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.